CD276 and colorectal cancer: Alongside B7-H3 antigen CRISPR knockout data (Fig. 2E), these data collectively demonstrate that B7-H3 mAb engages ADCC rather than immune checkpoint inhibition, resulting in reduced immunomodulation of stIL15-γδ T cells by colorectal cancer PDOs (Fig. 4C–E).